Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
The cabinet has approved four schemes which totally include Rs 13,760 crore to promote the domestic production of active pharmaceutical ingredients (APIs) and medical devices in the country and their exports.
Genentech, a member of the Roche Group announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra® (tocilizumab) plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia.
Dr Poonam Khetarpal Singh, regional director of the World Health Organisation (WHO) South-East Asia region, reported that there is no airborne case of the COVID-19 known yet.
Hydroxychloroquine and a related drug, chloroquine, are currently under evaluation in clinical trials for the treatment of COVID-19. Also, there are few results suggested that Hydroxychloroquine is effective against COVID-19. Three pharma giants Novartis, Mylan and Teva Pharma announced that they will donate millions of doses of hydroxychloroquine to support the global COVID-19 pandemic response.
Scientists from France conducted a small clinical trials and reported that hydroxychloroquine, an antimalarial medicine, treatment is significantly associated with viral load reduction or disappearance in COVID-19 patients and they also reported that azithromycin along with hydroxychloroquine can faster the recovery.
In the early days of a COVID‐19 infection outbreak, pediatric patients were rather rare, who were thought to be not susceptible to it. However, along with the emerging of familial aggregation, children suffered from COVID‐19 infection were gradually appeared. It is reported by researchers that Clinical and CT (computed tomography) features in pediatric patients with COVID‐19 infection are different than adults. The study was conducted by Dr. Jianbo Shao, MD, Department of Imaging Center, Wuhan Children's Hospital and team. And it is published in Pediatric Pulmonology on 5th March, 2020.
CLICK HERE TO SUBSCRIBE,
PHARMATUTOR's DAILY EMAILS
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
